In a filing, Dr. Reddy’s Laboratories Ltd. ADR revealed its Officer Israeli Erez acquired Company’s shares for reported $5.39 million on Jul 29 ’24. In the deal valued at $82.29 per share,65,500 shares were bought.
Nomura downgraded its Dr. Reddy’s Laboratories Ltd. ADR [RDY] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Jefferies’s analysts, who decreased its forecast for the stock in mid January from “a Buy” to “an Underperform”. HSBC Securities also remained covering RDY and has decreased its forecast on August 29, 2023 with a “Hold” recommendation from previously “Buy” rating. Bernstein revised its rating on May 18, 2023. It rated RDY as “a Mkt perform” which previously was an “an Outperform”.
Price Performance Review of RDY
On Tuesday, Dr. Reddy’s Laboratories Ltd. ADR [NYSE:RDY] saw its stock jump 1.62% to $15.67. Over the last five days, the stock has lost -0.25%. Dr. Reddy’s Laboratories Ltd. ADR shares have fallen nearly -0.76% since the year began. Nevertheless, the stocks have risen 11.09% over the past one year. While a 52-week high of $16.89 was reached on 01/07/25, a 52-week low of $13.43 was recorded on 01/06/25. SMA at 50 days reached $14.80, while 200 days put it at $15.15.
Levels Of Support And Resistance For RDY Stock
The 24-hour chart illustrates a support level at 15.48, which if violated will result in even more drops to 15.29. On the upside, there is a resistance level at 15.85. A further resistance level may holdings at 16.03. The Relative Strength Index (RSI) on the 14-day chart is 62.08, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 23.27%. Stochastics %K at 66.75% indicates the stock is a holding.
How much short interest is there in Dr. Reddy’s Laboratories Ltd. ADR?
A steep rise in short interest was recorded in Dr. Reddy’s Laboratories Ltd. ADR stocks on 2024-12-13, dropping by -0.81 million shares to a total of 10.83 million shares. Yahoo Finance data shows the prior-month short interest on 2024-11-15 was 11.64 million shares. There was a decline of -7.49%, which implies that there is a negative sentiment for the stock.
